insulin detemir vs octreotide
Side-by-side comparison of insulin detemir and octreotide. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
moderate Known Drug Interaction
Table 6: Clinically Significant Drug Interactions with LEVEMIR Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics, GLP-1 receptor agonists, DPP-4 inhibitors, SGLT-2 inhibitors.
Recommendation: Monitor your blood sugar closely and ask your doctor if your insulin dose needs to be adjusted.
Levemir
Sandostatin
Levemir is a long-acting insulin that helps control blood sugar levels in people with diabetes. It works slowly over about 24 hours to keep your blood sugar stable.
Octreotide is a drug that mimics a natural hormone in your body. It is used to treat certain conditions caused by too much of certain hormones.
Levemir is used to improve blood sugar control in adults and children with diabetes. It helps manage high blood sugar levels. However, it is not used to treat diabetic ketoacidosis, a serious condition with very high blood sugar and ketones.
Octreotide is used to lower growth hormone and insulin-like growth factor-1 in people with acromegaly who haven't responded to other treatments. It also helps manage severe diarrhea and flushing caused by carcinoid tumors. Additionally, it can treat watery diarrhea caused by VIPomas (tumors that release vasoactive intestinal peptide).
Levemir is a long-acting form of insulin. It works by helping your body use sugar from the blood for energy. This lowers your blood sugar levels and keeps them more stable over time.
This medicine works by mimicking somatostatin, a natural hormone in your body. It reduces the amount of certain hormones, like growth hormone, that your body makes. By doing this, it helps control the symptoms caused by having too much of these hormones.
- • Upper respiratory infection
- • Headache
- • Sore throat
- • Flu-like illness
- • Abdominal pain
- • Gallbladder problems
- • Slow heart rate
- • Diarrhea
- • Loose stools
- • Nausea
- High blood sugar 6,220
- Feeling sick to your stomach 1,971
- Low blood sugar 1,568
- Feeling tired 1,534
- Loose stools 1,399
- Diarrhea 526
- Death 375
- Nausea 345
- Tiredness 305
- Cancer getting worse 235
Never share your Levemir FlexPen, needle, or insulin syringe with anyone else, even if you change the needle. Sharing these items can spread blood-borne diseases. Changes in your insulin regimen can cause high or low blood sugar. Always check the insulin label before injecting to avoid medication errors. Low potassium can occur, monitor potassium levels. Heart failure can occur when taking Levemir with thiazolidinediones (TZDs).
Octreotide can cause heart problems, including a higher risk of certain types of heart block. Your doctor may monitor your heart if you receive this drug intravenously. It can also cause gallbladder problems, high or low blood sugar, and thyroid issues. Tell your doctor right away if you notice new or worsening symptoms.
Tell your doctor if you are pregnant or plan to become pregnant. Good control of diabetes is important during pregnancy for both you and your baby. Levemir can be used during pregnancy.
There is limited information about the safety of octreotide during pregnancy. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if octreotide passes into breast milk, so talk to your doctor about breastfeeding while using this medicine.
Also Compare, Nearby Drugs
Compare insulin detemir with
How to Read This insulin detemir vs octreotide Comparison
insulin detemir is classified in the Long-Acting Insulin drug class, while octreotide sits within the Somatostatin Analog class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, insulin detemir has 12,692 submissions while octreotide has 1,786. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known moderate interaction flagged in FDA labeling, attributed to octreotide can lower blood sugar, which adds to the effect of insulin and makes low blood sugar more likely.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between insulin detemir and octreotide - always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.